Dianthus Therapeutics, Inc. ( DNTH) - Stock Earnings
DNTH Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | 97.9 million USD | 284000 USD |
| 2026Q1 | -40.8 million USD | 463000 USD |
| 2026Q2 | -50.2 million USD | 761000 USD |
| 2026Q3 Est. | — | — |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
DNTH Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -43.6 million USD | 2.8 million USD |
| 2024 | -85.0 million USD | 6.2 million USD |
| 2025 | -162.3 million USD | 2.0 million USD |
| 2026 Est. | — | — |
DNTH
Price: $113.70
52 week price:
Earnings Per Share: -4.39 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 6.1 billion